BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26394221)

  • 1. Family Perception and 6-Month Symptomatic and Functioning Outcomes in Young Adolescents at Clinical High Risk for Psychosis in a General Population in China.
    Wang L; Shi J; Chen F; Yao Y; Zhan C; Yin X; Fang X; Wang H; Yuan J; Zhao X
    PLoS One; 2015; 10(9):e0138361. PubMed ID: 26394221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline putamen volume as a predictor of positive symptom reduction in patients at clinical high risk for psychosis: A preliminary study.
    Hong SB; Lee TY; Kwak YB; Kim SN; Kwon JS
    Schizophr Res; 2015 Dec; 169(1-3):178-185. PubMed ID: 26527246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective factors in Chinese university students at clinical high risk for psychosis.
    Shi J; Wang L; Yao Y; Chen F; Su N; Zhao X; Zhan C
    Psychiatry Res; 2016 May; 239():239-44. PubMed ID: 27031594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.
    Carrión RE; Demmin D; Auther AM; McLaughlin D; Olsen R; Lencz T; Correll CU; Cornblatt BA
    J Psychiatr Res; 2016 Oct; 81():95-101. PubMed ID: 27424062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family functioning moderates the impact of psychosis-risk symptoms on social and role functioning.
    Thompson E; Rakhshan P; Pitts SC; Demro C; Millman ZB; Bussell K; DeVylder J; Kline E; Reeves GM; Schiffman J
    Schizophr Res; 2019 Feb; 204():337-342. PubMed ID: 30205908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive family environment predicts improvement in symptoms and social functioning among adolescents at imminent risk for onset of psychosis.
    O'Brien MP; Gordon JL; Bearden CE; Lopez SR; Kopelowicz A; Cannon TD
    Schizophr Res; 2006 Jan; 81(2-3):269-75. PubMed ID: 16309893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of premorbid functioning in individuals at clinical high risk of psychosis.
    Lyngberg K; Buchy L; Liu L; Perkins D; Woods S; Addington J
    Schizophr Res; 2015 Dec; 169(1-3):209-213. PubMed ID: 26589390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course of clinical high-risk states for psychosis beyond conversion.
    Michel C; Ruhrmann S; Schimmelmann BG; Klosterkötter J; Schultze-Lutter F
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):39-48. PubMed ID: 28054132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
    Shin YS; Kim SY; Lee TY; Hur JW; Shin NY; Kim SN; Shin MS; Kwon JS
    Schizophr Res; 2016 Jul; 174(1-3):50-57. PubMed ID: 27068568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
    Fusar-Poli P; Salazar de Pablo G; Correll CU; Meyer-Lindenberg A; Millan MJ; Borgwardt S; Galderisi S; Bechdolf A; Pfennig A; Kessing LV; van Amelsvoort T; Nieman DH; Domschke K; Krebs MO; Koutsouleris N; McGuire P; Do KQ; Arango C
    JAMA Psychiatry; 2020 Jul; 77(7):755-765. PubMed ID: 32159746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
    Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting psychosis in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Kalska H; Mustonen U; Laajasalo T; Moilanen K; Huttunen M; Cannon TD; Suvisaari J; Therman S
    Schizophr Res; 2014 Sep; 158(1-3):1-6. PubMed ID: 25015028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms.
    Healy C; Byrne J; Raj Suasi S; Föcking M; Mongan D; Kodosaki E; Heurich M; Cagney G; Wynne K; Bearden CE; Woods SW; Cornblatt B; Mathalon D; Stone W; Cannon TD; Addington J; Cadenhead KS; Perkins D; Jeffries C; Cotter D
    Brain Behav Immun; 2024 Mar; 117():175-180. PubMed ID: 38219978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
    Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
    JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.
    Schlosser DA; Campellone TR; Biagianti B; Delucchi KL; Gard DE; Fulford D; Stuart BK; Fisher M; Loewy RL; Vinogradov S
    Schizophr Res; 2015 Dec; 169(1-3):204-208. PubMed ID: 26530628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial.
    Miklowitz DJ; O'Brien MP; Schlosser DA; Addington J; Candan KA; Marshall C; Domingues I; Walsh BC; Zinberg JL; De Silva SD; Friedman-Yakoobian M; Cannon TD
    J Am Acad Child Adolesc Psychiatry; 2014 Aug; 53(8):848-58. PubMed ID: 25062592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coping styles of individuals at clinical high risk for developing psychosis.
    Jalbrzikowski M; Sugar CA; Zinberg J; Bachman P; Cannon TD; Bearden CE
    Early Interv Psychiatry; 2014 Feb; 8(1):68-76. PubMed ID: 23164368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium.
    Tronick LN; Mirzakhanian H; Addington J; Bearden CE; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2023 Aug; 17(8):759-770. PubMed ID: 36627192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.